Content-type: text/application/x-research-info-systems

TY  - JOUR
AU  - Brandes, A A
AU  - Tosoni, A
AU  - Cavallo, G
AU  - Bertorelle, R
AU  - Gioia, V
AU  - Franceschi, E
AU  - Biscuola, M
AU  - Blatt, V
AU  - Crino, L
AU  - Ermani, M
TI  - Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
JA  - Br J Cancer
PY  - 2006/10/03/online
VL  - 95
IS  - 9
SP  - 1155
EP  - 1160
PB  - Cancer Research UK
SN  - 0007-0920
UR  - http://dx.doi.org/10.1038/sj.bjc.6603376
ER  -